Breaking News Instant updates and real-time market news.

GD

General Dynamics

$138.54 /

-0.09 (-0.06%)

17:14
09/30/20
09/30
17:14
09/30/20
17:14

General Dynamics awarded $1.22B hybrid Army contract

General Dynamics was awarded a $1.22B hybrid contract to produce, test and deliver Interim Maneuver Short-Range Air Defense, or IM-SHORAD, systems. One bid was solicited with one bid received. Work locations and funding will be determined with each order, with an estimated completion date of September 30, 2025. U.S. Army Contracting Command is the contracting activity.

GD General Dynamics
$138.54 /

-0.09 (-0.06%)

09/17/20
Fly Intel: Top five analyst downgrades
09/17/20 Goldman Sachs
General Dynamics downgraded to Sell from Buy at Goldman Sachs
09/08/20 Morgan Stanley
General Dynamics initiated with an Underweight at Morgan Stanley
08/03/20
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Recommendations
Ecolab price target raised to $180 from $172 at Credit Suisse » 08:08
10/28/20
10/28
08:08
10/28/20
08:08
ECL

Ecolab

$189.85 /

-8.77 (-4.42%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

07:36 Today BMO Capital
Ecolab price target raised to $195 from $187 at BMO Capital
06:53 Today Deutsche Bank
Ecolab price target lowered to $200 from $210 at Deutsche Bank
09/21/20 Evercore ISI
Ecolab initiated with an Outperform at Evercore ISI
09/08/20 BMO Capital
Ecolab price target raised to $187 from $177 at BMO Capital
ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

ECL Ecolab
$189.85 /

-8.77 (-4.42%)

Earnings
Dine Brands reports Q3 EPS 80c, consensus 36c » 08:07
10/28/20
10/28
08:07
10/28/20
08:07
DIN

Dine Brands

$56.64 /

+0.69 (+1.23%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
10/14/20 Wedbush
Dine Brands price target raised to $70 from $55 at Wedbush
07/30/20 Wedbush
Dine Brands price target raised to $55 from $50 at Wedbush
07/30/20 Deutsche Bank
Dine Brands price target raised to $45 from $40 at Deutsche Bank
DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

DIN Dine Brands
$56.64 /

+0.69 (+1.23%)

Hot Stocks
Keurig Dr Pepper signs distribution pact with The Honickman Companies » 08:07
10/28/20
10/28
08:07
10/28/20
08:07
KDP

Keurig Dr Pepper

$28.60 /

+0.17 (+0.60%)

Keurig Dr Pepper and The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

10/20/20 Jefferies
National Beverage upgraded to Hold on better La Croix market share at Jefferies
08/27/20 Jefferies
Keurig Dr Pepper has long runway for pod category growth, says Jefferies
08/26/20
Fly Intel: Top five analyst upgrades
08/26/20 Morgan Stanley
Keurig Dr Pepper upgraded to Overweight on coffee 'boost' at Morgan Stanley
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

  • 18
    Aug
  • 03
    Aug
  • 21
    May
  • 05
    Mar
KDP Keurig Dr Pepper
$28.60 /

+0.17 (+0.60%)

Hot Stocks
General Electric: 'Our markets are, by and large, stabilizing' » 08:06
10/28/20
10/28
08:06
10/28/20
08:06
GE

General Electric

$7.10 /

-0.29 (-3.92%)

Comments taken from Q3…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

10/13/20 Deutsche Bank
General Electric price target raised to $6.81 from $6.25 at Deutsche Bank
10/09/20 Goldman Sachs
Goldman sees 50% upside in General Electric, reinstates shares at Buy
09/17/20 JPMorgan
Those calling GE guidance 'inflection' misunderstand business, says JPMorgan
08/31/20 JPMorgan
JPMorgan's Tusa withdraws GE price target, sees fair value below $5
GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

GE General Electric
$7.10 /

-0.29 (-3.92%)

Earnings
First Merchants reports Q3 EPS 67c, consensus 62c » 08:06
10/28/20
10/28
08:06
10/28/20
08:06
FRME

First Merchants

$26.52 /

-0.58 (-2.14%)

Reports tangible common…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRME First Merchants
$26.52 /

-0.58 (-2.14%)

FRME First Merchants
$26.52 /

-0.58 (-2.14%)

06/17/20 Raymond James
First Merchants downgraded to Market Perform from Outperform at Raymond James
04/09/20 Stephens
First Merchants downgraded to Equal Weight on near-term risks at Stephens
04/09/20 Stephens
First Merchants downgraded to Equal Weight from Overweight at Stephens
FRME First Merchants
$26.52 /

-0.58 (-2.14%)

Hot Stocks
MasterCard seeing 'encouraging' progress in domestic spending trajectory » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
MA

MasterCard

$317.12 /

-0.985 (-0.31%)

"Mastercard has been…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
MasterCard price target raised to $330 from $305 at Jefferies
09/21/20 Barclays
MasterCard price target raised to $385 from $360 at Barclays
09/15/20 Deutsche Bank
MasterCard price target raised to $383 from $320 at Deutsche Bank
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

Hot Stocks
AbbVie's presbyopia candidate meets efficacy endpoint in Phase 3 trial » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
ABBV

AbbVie

$82.69 /

-1.2 (-1.43%)

AbbVie company Allergan …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
AbbVie initiated with a Buy at Truist
10/20/20 Goldman Sachs
Galapagos downgraded to Sell from Neutral at Goldman Sachs
ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

ABBV AbbVie
$82.69 /

-1.2 (-1.43%)

Earnings
MasterCard reports Q3 adjusted EPS $1.60, consensus $1.66 » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
MA

MasterCard

$317.12 /

-0.985 (-0.31%)

Reports Q3 revenue $3.8B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

10/05/20 Morgan Stanley
Repay Holdings initiated with an Equal Weight at Morgan Stanley
10/02/20 Jefferies
MasterCard price target raised to $330 from $305 at Jefferies
09/21/20 Barclays
MasterCard price target raised to $385 from $360 at Barclays
09/15/20 Deutsche Bank
MasterCard price target raised to $383 from $320 at Deutsche Bank
MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

MA MasterCard
$317.12 /

-0.985 (-0.31%)

Hot Stocks
Norfolk Southern reports Q3 adjusted operating ratio 62.5% » 08:05
10/28/20
10/28
08:05
10/28/20
08:05
NSC

Norfolk Southern

$203.55 /

-7.05 (-3.35%)

The adjusted operating…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight with $230 target at Barclays
10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight from Underweight at Barclays
10/08/20 Susquehanna
Norfolk Southern price target raised to $286 from $284 at Susquehanna
10/08/20 Citi
Norfolk Southern price target raised to $250 from $214 at Citi
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

Recommendations
Raytheon Technologies price target lowered to $70 from $75 at Credit Suisse » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
RTX

Raytheon Technologies

$56.45 /

-4.44 (-7.29%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

10/12/20 Credit Suisse
Raytheon Technologies price target lowered to $75 from $81 at Credit Suisse
09/20/20 Goldman Sachs
Lockheed Martin downgraded to Buy from Conviction Buy at Goldman Sachs
09/20/20 Goldman Sachs
Raytheon upgraded to Conviction Buy from Buy at Goldman Sachs
09/08/20 Morgan Stanley
Raytheon Technologies initiated with an Overweight at Morgan Stanley
RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

RTX Raytheon Technologies
$56.45 /

-4.44 (-7.29%)

Earnings
Crispr Therapeutics reports Q3 EPS ($1.32), consensus ($1.18) » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
CRSP

Crispr Therapeutics

$98.05 /

+3.94 (+4.19%)

Reports Q3 revenue $0.1M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

10/22/20 RBC Capital
Crispr Therapeutics initiated with a Sector Perform at RBC Capital
10/22/20 Chardan
Crispr Therapeutics price target raised to $110 from $100 at Chardan
10/22/20 Canaccord
Crispr Therapeutics price target raised to $120 from $110 at Canaccord
10/22/20 Citi
Crispr Therapeutics price target raised to $47 from $31 at Citi
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

  • 01
    Jul
  • 21
    Nov
CRSP Crispr Therapeutics
$98.05 /

+3.94 (+4.19%)

Earnings
Popular reports Q3 EPS $2.00, consensus $1.20 » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
BPOP

Popular

$39.26 /

-1.31 (-3.23%)

Net interest income for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BPOP Popular
$39.26 /

-1.31 (-3.23%)

BPOP Popular
$39.26 /

-1.31 (-3.23%)

09/22/20
Top five analyst initiations
09/22/20 UBS
Popular initiated with a Neutral at UBS
07/07/20 RBC Capital
Popular price target lowered to $48 from $58 at RBC Capital
03/27/20 BTIG
Popular price target lowered to $54 from $60 at BTIG
BPOP Popular
$39.26 /

-1.31 (-3.23%)

Earnings
Dynex Capital reports Q3 core EPS 61c, consensus 47c » 08:03
10/28/20
10/28
08:03
10/28/20
08:03
DX

Dynex Capital

$16.00 /

+0.21 (+1.33%)

Reports Q3 book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

07/29/20 Ladenburg
Dynex Capital upgraded to Buy from Neutral at Ladenburg
01/14/20 JonesTrading
Dynex Capital initiated with a Buy at JonesTrading
11/26/19
Fly Intel: Top five analyst upgrades
11/25/19 Keefe Bruyette
Dynex Capital upgraded to Outperform from Market Perform at Keefe Bruyette
DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

DX Dynex Capital
$16.00 /

+0.21 (+1.33%)

Hot Stocks
ADP jumps nearly 5% to $153 after Q1 earnings beat, raised FY21 guidance  08:03
10/28/20
10/28
08:03
10/28/20
08:03
ADP

ADP

$145.95 /

+0.24 (+0.16%)

 
ShowHide Related Items >><<
ADP ADP
$145.95 /

+0.24 (+0.16%)

ADP ADP
$145.95 /

+0.24 (+0.16%)

10/27/20 Credit Suisse
TriNet price target raised to $66 from $54 at Credit Suisse
09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Cowen
ADP downgraded to Market Perform on lack of catalysts at Cowen
09/21/20 Cowen
ADP downgraded to Market Perform from Outperform at Cowen
ADP ADP
$145.95 /

+0.24 (+0.16%)

ADP ADP
$145.95 /

+0.24 (+0.16%)

Recommendations
Cummins price target raised to $273 from $257 at Credit Suisse » 08:01
10/28/20
10/28
08:01
10/28/20
08:01
CMI

Cummins

$219.76 /

-1.09 (-0.49%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMI Cummins
$219.76 /

-1.09 (-0.49%)

CMI Cummins
$219.76 /

-1.09 (-0.49%)

06:54 Today Deutsche Bank
Cummins price target raised to $242 from $221 at Deutsche Bank
06:34 Today Citi
Cummins price target raised to $260 from $250 at Citi
10/19/20 Baird
Cummins reinstated with a Neutral at Baird
10/16/20 Citi
Cummins price target raised to $250 from $215 at Citi
CMI Cummins
$219.76 /

-1.09 (-0.49%)

CMI Cummins
$219.76 /

-1.09 (-0.49%)

Recommendations
Crocs price target raised to $68 from $53 at Susquehanna » 08:01
10/28/20
10/28
08:01
10/28/20
08:01
CROX

Crocs

$54.80 /

+2.69 (+5.16%)

Susquehanna analyst Sam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

07:52 Today Baird
Crocs price target raised to $72 from $50 at Baird
07:21 Today Stifel
Crocs price target raised to $50 from $42 at Stifel
06:43 Today UBS
Crocs price target raised to $57 from $48 at UBS
06:41 Today Loop Capital
Crocs price target raised to $60 from $50 at Loop Capital
CROX Crocs
$54.80 /

+2.69 (+5.16%)

  • 31
    Oct
CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

CROX Crocs
$54.80 /

+2.69 (+5.16%)

Earnings
Norfolk Southern reports Q3 adjusted EPS $2.51, consensus $2.38 » 08:01
10/28/20
10/28
08:01
10/28/20
08:01
NSC

Norfolk Southern

$203.55 /

-7.05 (-3.35%)

Reports Q3 revenue $2.5B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight with $230 target at Barclays
10/16/20 Barclays
Norfolk Southern upgraded to Equal Weight from Underweight at Barclays
10/08/20 Susquehanna
Norfolk Southern price target raised to $286 from $284 at Susquehanna
10/08/20 Citi
Norfolk Southern price target raised to $250 from $214 at Citi
NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

NSC Norfolk Southern
$203.55 /

-7.05 (-3.35%)

Syndicate
Ultragenyx files to sell $400M in common stock » 08:01
10/28/20
10/28
08:01
10/28/20
08:01
RARE

Ultragenyx

$97.50 /

+6.36 (+6.98%)

J.P. Morgan, Goldman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RARE Ultragenyx
$97.50 /

+6.36 (+6.98%)

RARE Ultragenyx
$97.50 /

+6.36 (+6.98%)

06:30 Today Barclays
Ultragenyx price target raised to $121 from $99 at Barclays
10/27/20 Piper Sandler
Ultragenyx price target raised to $108 from $83 at Piper Sandler
10/23/20 Piper Sandler
Ultragenyx deal with Solid Biosciences looks 'solid,' says Piper Sandler
07/31/20 Barclays
Ultragenyx price target raised to $99 from $87 at Barclays
RARE Ultragenyx
$97.50 /

+6.36 (+6.98%)

RARE Ultragenyx
$97.50 /

+6.36 (+6.98%)

Recommendations
Intel price target lowered to $40 from $45 at RBC Capital » 08:00
10/28/20
10/28
08:00
10/28/20
08:00
INTC

Intel

$45.65 /

-1.06 (-2.27%)

, AMD

AMD

$78.83 /

-3.42 (-4.16%)

, XLNX

Xilinx

$124.27 /

+9.71 (+8.48%)

RBC Capital analyst Mitch…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INTC Intel
$45.65 /

-1.06 (-2.27%)

AMD AMD
$78.83 /

-3.42 (-4.16%)

XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

INTC Intel
$45.65 /

-1.06 (-2.27%)

07:39 Today Oppenheimer
AMD acquisition of Xilinx complements strong Q3 results, says Oppenheimer
10/27/20 Barclays
Barclays upgrades AMD to Overweight on gains while Intel struggles
10/23/20
Fly Intel: Top five analyst downgrades
10/23/20 Truist
Intel price target lowered to $51 from $61 at Truist
AMD AMD
$78.83 /

-3.42 (-4.16%)

07:45 Today Craig-Hallum
AMD upgraded to Buy at Craig-Hallum on quarterly results, Xilinx acquisition
07:39 Today Oppenheimer
AMD acquisition of Xilinx complements strong Q3 results, says Oppenheimer
07:26 Today Loop Capital
AMD price target raised to $95 from $85 at Loop Capital
07:02 Today Craig-Hallum
AMD upgraded to Buy from Hold at Craig-Hallum
XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

07:39 Today Oppenheimer
AMD acquisition of Xilinx complements strong Q3 results, says Oppenheimer
07:26 Today Loop Capital
AMD price target raised to $95 from $85 at Loop Capital
06:49 Today Mizuho
AMD price target raised to $93 from $90 at Mizuho
05:59 Today JPMorgan
Xilinx upgraded to Neutral from Underweight at JPMorgan
INTC Intel
$45.65 /

-1.06 (-2.27%)

AMD AMD
$78.83 /

-3.42 (-4.16%)

XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

INTC Intel
$45.65 /

-1.06 (-2.27%)

AMD AMD
$78.83 /

-3.42 (-4.16%)

XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

INTC Intel
$45.65 /

-1.06 (-2.27%)

AMD AMD
$78.83 /

-3.42 (-4.16%)

XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

INTC Intel
$45.65 /

-1.06 (-2.27%)

AMD AMD
$78.83 /

-3.42 (-4.16%)

XLNX Xilinx
$124.27 /

+9.71 (+8.48%)

Recommendations
C.H. Robinson's next few quarters to be 'very challenging,' says Morgan Stanley » 08:00
10/28/20
10/28
08:00
10/28/20
08:00
CHRW

C.H. Robinson

$100.00 /

+0.41 (+0.41%)

After C.H. Robinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHRW C.H. Robinson
$100.00 /

+0.41 (+0.41%)

CHRW C.H. Robinson
$100.00 /

+0.41 (+0.41%)

10/16/20 Barclays
C.H. Robinson price target raised to $115 from $95 at Barclays
09/23/20 Wells Fargo
C.H. Robinson initiated with an Underweight at Wells Fargo
08/17/20 Baird
C.H. Robinson downgraded to Neutral at Baird
08/17/20 Baird
C.H. Robinson downgraded to Neutral from Outperform at Baird
CHRW C.H. Robinson
$100.00 /

+0.41 (+0.41%)

CHRW C.H. Robinson
$100.00 /

+0.41 (+0.41%)

CHRW C.H. Robinson
$100.00 /

+0.41 (+0.41%)

Earnings
Ryder reports Q EPS $1.21, consensus (32c) » 07:59
10/28/20
10/28
07:59
10/28/20
07:59
R

Ryder

$50.33 /

-0.31 (-0.61%)

Reports Q revenue $2.15B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
R Ryder
$50.33 /

-0.31 (-0.61%)

R Ryder
$50.33 /

-0.31 (-0.61%)

10/09/20 JPMorgan
Ryder upgraded to Neutral on rising prices at JPMorgan
10/09/20 JPMorgan
Ryder upgraded to Neutral from Underweight at JPMorgan
09/23/20 Wells Fargo
Ryder initiated with an Underweight at Wells Fargo
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
R Ryder
$50.33 /

-0.31 (-0.61%)

R Ryder
$50.33 /

-0.31 (-0.61%)

Recommendations
First Solar price target raised to $125 from $97 at Baird » 07:58
10/28/20
10/28
07:58
10/28/20
07:58
FSLR

First Solar

/

+

Baird analyst Ben Kallo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLR First Solar
/

+

FSLR First Solar
/

+

06:24 Today Barclays
First Solar upgraded to Equal Weight with $86 target at Barclays
04:48 Today Barclays
First Solar upgraded to Equal Weight from Underweight at Barclays
10/26/20 Credit Suisse
First Solar downgraded to Underperform at Credit Suisse
10/26/20 Roth Capital
First Solar upgraded to Buy at Roth Capital on policy drivers
FSLR First Solar
/

+

  • 17
    Sep
FSLR First Solar
/

+

FSLR First Solar
/

+

Recommendations
Cards stacked against Biogen into aducanumab FDA panel, says Baird » 07:58
10/28/20
10/28
07:58
10/28/20
07:58
BIIB

Biogen

$255.31 /

-1.575 (-0.61%)

The cards are stacked…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$255.31 /

-1.575 (-0.61%)

BIIB Biogen
$255.31 /

-1.575 (-0.61%)

06:25 Today UBS
Biogen initiated with a Neutral at UBS
10/27/20 Mizuho
Biogen 'starting to look interesting again,' says Mizuho
10/22/20 Stifel
'Hard to have conviction' in Biogen Aducanumab approval, says Stifel
10/22/20 Wedbush
Biogen price target lowered to $244 from $281 at Wedbush
BIIB Biogen
$255.31 /

-1.575 (-0.61%)

BIIB Biogen
$255.31 /

-1.575 (-0.61%)

BIIB Biogen
$255.31 /

-1.575 (-0.61%)

BIIB Biogen
$255.31 /

-1.575 (-0.61%)

BIIB Biogen
$255.31 /

-1.575 (-0.61%)

Recommendations
Sherwin-Williams price target raised to $778 from $765 at Credit Suisse » 07:57
10/28/20
10/28
07:57
10/28/20
07:57
SHW

Sherwin-Williams

$673.59 /

+2.89 (+0.43%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SHW Sherwin-Williams
$673.59 /

+2.89 (+0.43%)

SHW Sherwin-Williams
$673.59 /

+2.89 (+0.43%)

06:33 Today Citi
Sherwin-Williams price target raised to $818 from $800 at Citi
06:03 Today JPMorgan
Sherwin-Williams upgraded on upcoming price increase catalyst at JPMorgan
04:45 Today JPMorgan
Sherwin-Williams upgraded to Overweight from Neutral at JPMorgan
10/20/20 Morgan Stanley
Sherwin-Williams price target raised to $785 from $700 at Morgan Stanley
SHW Sherwin-Williams
$673.59 /

+2.89 (+0.43%)

SHW Sherwin-Williams
$673.59 /

+2.89 (+0.43%)

SHW Sherwin-Williams
$673.59 /

+2.89 (+0.43%)

Recommendations
Shutterstock price target raised to $75 from $60 at Truist » 07:56
10/28/20
10/28
07:56
10/28/20
07:56
SSTK

Shutterstock

$69.56 /

+7.345 (+11.81%)

Truist analyst Youssef…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSTK Shutterstock
$69.56 /

+7.345 (+11.81%)

SSTK Shutterstock
$69.56 /

+7.345 (+11.81%)

10/27/20 Truist
Shutterstock price target raised to $75 from $60 at Truist
10/27/20 Needham
Shutterstock price target raised to $88 from $65 at Needham
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Stifel
Shutterstock initiated with a Buy at Stifel
SSTK Shutterstock
$69.56 /

+7.345 (+11.81%)

  • 12
    Aug
SSTK Shutterstock
$69.56 /

+7.345 (+11.81%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.